UMIN-ICDS History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000047886 |
|---|---|
| Receipt number | R000054594 |
| Scientific Title | TRIAL HAS BEEN RENDERED NULL AND VOIDED, SHOULD NOT BE UTILIZED BY ANYONE. THE PRODUCT BELONGS TO SOMEONE ELSE. |
| Date of disclosure of the study information | 2022/12/31 |
| Last modified on | 2023/12/31 19:13:57 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2022/05/28 16:45:21 | ||
| 2 | Update | 2022/05/30 16:08:14 | Date of IRB |
|
| 3 | Update | 2022/05/30 16:11:21 | Address Address Address Institute Name of secondary funder(s) Research ethics review Address1 Address |
|
| 4 | Update | 2022/05/31 16:52:06 | Number of participants that the trial has enrolled Results Results date posted |
|
| 5 | Update | 2022/06/09 03:03:27 | Last name of lead principal investigator Organization Address Last name of contact person Organization Address Name of person sending information Organization Address Institute Organization Co-sponsor Organization1 Address1 Organization Address |
|
| 6 | Update | 2022/06/16 20:18:36 | Last name of lead principal investigator Organization Address Last name of contact person Organization Address Name of person sending information Organization Address Institute Organization Co-sponsor Name of secondary funder(s) Organization1 Address1 Organization Address |
|
| 7 | Update | 2022/07/08 18:29:45 | Last name of lead principal investigator Organization Address Last name of contact person Organization Address TEL Name of person sending information Organization Address Institute Organization Co-sponsor Name of secondary funder(s) Organization1 Address1 Organization Address |
|
| 8 | Update | 2022/07/13 01:42:59 | Middle name of lead principal investigator Name of person sending information Organization Co-sponsor Name of secondary funder(s) |
|
| 9 | Update | 2022/07/14 20:19:25 | Last name of lead principal investigator Name of secondary funder(s) |
|
| 10 | Update | 2022/07/22 06:24:44 | Last name of lead principal investigator Organization Address Organization Address Name of person sending information Organization Address TEL Institute Organization Co-sponsor Name of secondary funder(s) Organization1 Address1 Organization Address |
|
| 11 | Update | 2022/07/31 04:52:57 | Last name of contact person Name of person sending information Organization Co-sponsor |
|
| 12 | Update | 2022/08/02 18:05:41 | Last name of lead principal investigator Name of secondary funder(s) |
|
| 13 | Update | 2022/08/08 15:55:25 | Last name of lead principal investigator |
|
| 14 | Update | 2022/08/11 18:11:53 | Last name of lead principal investigator Name of person sending information Organization1 |
|
| 15 | Update | 2022/08/11 19:37:22 | Organization Address Organization Address Institute Co-sponsor Organization1 Address1 Organization Address |
|
| 16 | Update | 2022/08/16 04:40:43 | Last name of lead principal investigator Organization Address Last name of contact person Organization Address Name of person sending information Organization Address Institute Organization Co-sponsor Name of secondary funder(s) Organization1 Address1 Organization Address |
|
| 17 | Update | 2022/08/16 07:53:09 | Last name of lead principal investigator Address Address Name of person sending information Address Institute Organization1 Address1 Address |
|
| 18 | Update | 2022/08/22 10:48:01 | Scientific Title:Acronym |
|
| 19 | Update | 2022/08/23 21:36:45 | Email Institute Email1 |
|
| 20 | Update | 2022/08/30 17:55:44 | Email |
|
| 21 | Update | 2022/08/30 17:57:16 | Results |
|
| 22 | Update | 2022/09/08 05:13:04 | TEL TEL TEL Co-sponsor Tel1 Tel |
|
| 23 | Update | 2022/09/08 05:37:53 | Email Institute Email1 |
|
| 24 | Update | 2022/09/08 05:44:40 | Institute |
|
| 25 | Update | 2022/09/20 02:09:53 | Organization |
|
| 26 | Update | 2022/10/02 04:30:36 | Organization Organization Institute |
|
| 27 | Update | 2022/10/02 04:32:40 | Public title Region |
|
| 28 | Update | 2022/10/02 18:13:33 | Organization |
|
| 29 | Update | 2022/10/15 22:23:57 | Organization Organization Organization Co-sponsor Organization1 |
|
| 30 | Update | 2022/11/09 04:25:24 | Division name Division name Homepage URL Division name Institute Address1 Address |
|
| 31 | Update | 2022/11/09 04:28:55 | URL releasing protocol URL related to results and publications Results |
|
| 32 | Update | 2022/11/15 23:45:05 | Zip code Address TEL Organization Address TEL Address TEL Institute Address1 Tel1 Address Tel |
|
| 33 | Update | 2022/12/08 22:59:48 | Middle name of lead principal investigator Organization Zip code Address Organization Zip code Address Organization Address Institute Organization Nationality of Funding Organization Co-sponsor Name of secondary funder(s) Organization1 Address1 Address |
|
| 34 | Update | 2022/12/08 23:02:49 | Public title |
|
| 35 | Update | 2023/01/06 01:02:20 | TEL Address TEL Tel |
|
| 36 | Update | 2023/02/01 02:51:10 | 1st name of lead principal investigator Middle name of lead principal investigator Institute Email1 |
|
| 37 | Update | 2023/02/01 18:14:23 | Email Institute Email1 |
|
| 38 | Update | 2023/02/08 02:05:29 | Public title Acronym Scientific Title Scientific Title:Acronym Region |
|
| 39 | Update | 2023/02/08 02:11:28 | Condition Classification by specialty Narrative objectives1 Basic objectives2 Basic objectives -Others Primary outcomes Key secondary outcomes |
|
| 40 | Update | 2023/02/08 02:28:58 | Study type Basic design Randomization Blinding Control No. of arms Purpose of intervention Type of intervention Interventions/Control_1 Gender Key inclusion criteria Key exclusion criteria Target sample size |
|
| 41 | Update | 2023/02/08 02:35:20 | 1st name of lead principal investigator Last name of lead principal investigator Organization Division name Zip code Address TEL Last name of contact person Organization Division name Zip code Address TEL Homepage URL Name of person sending information Organization Division name Address TEL Institute Organization Category of Funding Organization Nationality of Funding Organization Co-sponsor Name of secondary funder(s) Research ethics review Organization1 Address1 Tel1 Email1 Organization Address Tel |
|
| 42 | Update | 2023/02/08 02:37:44 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Delayed Results Delay Reason Baseline Characteristics Participant flow Outcome measures |
|
| 43 | Update | 2023/02/08 02:39:31 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date Other related information |
|
| 44 | Update | 2023/06/28 21:41:13 | Public title Acronym Scientific Title Scientific Title:Acronym |
|
| 45 | Update | 2023/06/28 21:42:50 | Condition Narrative objectives1 Basic objectives -Others Primary outcomes Key secondary outcomes |
|
| 46 | Update | 2023/06/28 21:43:57 | Key inclusion criteria Key exclusion criteria |
|
| 47 | Update | 2023/06/28 21:46:28 | Organization Division name Zip code Address Organization Division name Zip code Address Organization Division name Address Institute Organization Organization1 Address1 Organization Address Tel |
|
| 48 | Update | 2023/06/28 21:48:17 | URL releasing protocol URL related to results and publications Results Results Delayed Results Delay Reason Baseline Characteristics Participant flow Outcome measures |
|
| 49 | Update | 2023/06/28 21:50:53 | Date of IRB Anticipated trial start date Last follow-up date Other related information |
|
| 50 | Update | 2023/09/24 03:20:11 | Email Email1 |
|
| 51 | Update | 2023/11/02 04:25:39 | Email Email1 |
|
| 52 | Update | 2023/11/02 04:30:32 | Email Email1 |
|
| 53 | Update | 2023/11/04 20:34:56 | Narrative objectives1 Basic objectives -Others Primary outcomes Key secondary outcomes |
|
| 54 | Update | 2023/12/31 18:53:14 | Public title Scientific Title |
|
| 55 | Update | 2023/12/31 18:56:00 | Condition Narrative objectives1 Basic objectives -Others Primary outcomes Key secondary outcomes |
|
| 56 | Update | 2023/12/31 18:58:20 | Key inclusion criteria Key exclusion criteria |
|
| 57 | Update | 2023/12/31 19:08:05 | Organization Division name Zip code Address Organization Division name Zip code Address Organization Division name Address Institute Organization Organization1 Address1 Email1 Organization Address Tel |
|
| 58 | Update | 2023/12/31 19:11:44 | URL releasing protocol URL related to results and publications Number of participants that the trial has enrolled Results Results Delay Reason Baseline Characteristics Participant flow Adverse events Outcome measures |
|
| 59 | Update | 2023/12/31 19:13:57 | Date of IRB Anticipated trial start date Last follow-up date Other related information |
